179: EARLY PREDICTION OF PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY FOR OESOPHAGEAL CANCER USING FULLY HYBRID PET/MR: PRELIMINARY RESULTS

MLA

D Palumbo, et al. “179: Early Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy for Oesophageal Cancer Using Fully Hybrid Pet/Mr: Preliminary Results.” Diseases of the Esophagus, vol. 35, Apr. 2022. EBSCOhost, https://doi.org/10.1093/dote/doac015.179.

APA

D Palumbo, C Fiorino, M Mori, M Picchio, A Cossu, N Slim, F Puccetti, E Mazza, S Steidler, N Di Muzio, S Cascinu, L Gianolli, R Rosati, & F De Cobelli. (2022). 179: Early Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy for Oesophageal Cancer Using Fully Hybrid Pet/Mr: Preliminary Results. Diseases of the Esophagus, 35. https://doi.org/10.1093/dote/doac015.179

Chicago

D Palumbo, C Fiorino, M Mori, M Picchio, A Cossu, N Slim, F Puccetti, et al. 2022. “179: Early Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy for Oesophageal Cancer Using Fully Hybrid Pet/Mr: Preliminary Results.” Diseases of the Esophagus 35 (April). doi:10.1093/dote/doac015.179.